Muhammad Akbar Ramadhan Munandar, Hendra Priatna Munandar, and Liana Herlina. “Cost-Effectiveness of Pembrolizumab As First-Line Treatment for PD-L1 Positive NSCLC: A Systematic Review”. The International Journal of Medical Science and Health Research 23, no. 2 (January 4, 2026): 64–130. Accessed October 21, 2026. https://internationalmedicaljournal.org/index.php/ijmhsr/article/view/461.